Nicholson, C. David bought ATNM
September 2, 2026 · Form 4 insider transaction
Nicholson, C. David bought 94,200 shares of Actinium Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
94,200
Price
$0.00
Total value
N/A
InsiderNicholson, C. David
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2026
Filing dateSeptember 4, 2026
Shares owned after94,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.